Recent News

• 03.23.2026 - Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
• 03.03.2026 - Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
• 11.13.2025 - Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Recent Filings

• 03.23.2026 - EX-99.1 EX-99.1
• 03.23.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.23.2026 - 8-K Current report
• 03.03.2026 - EX-99.1 EX-99.1
• 03.03.2026 - 8-K Current report
• 02.20.2026 - 8-K Current report
• 02.20.2026 - EX-99.1 EX-99.1
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.11.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.06.2026 - 8-K Current report